Biotech
1 ticker uses this canonical theme · 1 high confidence
Unclustered (1)
| Ticker | Conf. | Primary theme | Sub-industry |
|---|---|---|---|
| CTMX | high | Probody Platform CytomX's Probody platform enables tumor-specific activation of biologic drugs; upcoming data readouts and cash runway through 2028 support near-term value. | Biotechnology |
★ = primary thesis · click ticker for full detail · cluster grouping reflects the latest cluster snapshot.